QGEN Qiagen N.V.

NYSE
$42.95

Qiagen N.V. (QGEN) is expected to report earnings on November 4, 2026, after the market close. The consensus earnings estimate is $0.62 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of +1.3% since its last earnings release on August 5, 2026.

Qiagen N.V. Beat Consensus Estimates, Reaffirms
Wednesday, August 5, 2026 · 4:05 PM ET
Earnings Date
3rd Quarter, Sep 2026
Nov 4
Wednesday · 4:05 PM ET
Earnings Whisper
-
vs $0.62
Rev est $552.19M
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP $42.76

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

About Qiagen N.V.

Qiagen NV provides sample and assay technologies. It also offers kits, assays, related automated systems and bioinformatics solutions, that cover the entire continuum from basic life sciences research to clinical diagnostics.

Sector

Healthcare

Industry

Diagnostic Substances